What is Polaryx Therapeutics, Inc. 's change in AP?

Polaryx Therapeutics, Inc. (PLYX) reported change in AP of $380K in Q1 2026.

How has Polaryx Therapeutics, Inc. 's change in AP changed year-over-year?

Polaryx Therapeutics, Inc. 's change in AP increased by 2335.3% year-over-year, from -$17K to $380K.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Polaryx Therapeutics, Inc. PLYX Change in AP

Change in AP at other companies

BioMarin PharmaceuticalsBMRN

$3.1M+217%

Zevra Therapeutics, Inc.ZVRA

-$529K+92.7%

Eton Pharmaceuticals, Inc.ETON

$2.51M+256%

XER

Xeris Biopharma Holdings, Inc.XERS

$4.25M+4.6%

Relay Therapeutics, Inc.RLAY

$3.67M+206%

PVL

Palvella TherapeuticsPVLA

$851K-24.3%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-86.9%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's change in AP?: Polaryx Therapeutics, Inc. (PLYX) reported change in AP of $380K in Q1 2026.
How has Polaryx Therapeutics, Inc. 's change in AP changed year-over-year?: Polaryx Therapeutics, Inc. 's change in AP increased by 2335.3% year-over-year, from -$17K to $380K.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.